Trial Identifier: | D169CR00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05188144 |
Start Date: | November 2021 |
Primary Completion Date: | March 2024 |
Study Completion Date: | March 2024 |
Condition: | Congestive Heart Failure |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
United Kingdom, Berkshire | Reading, Berkshire, United Kingdom, RG1 5AN |
United Kingdom, Cornwall | Truro, Cornwall, United Kingdom, TR1 3LJ |
United Kingdom, County Armagh | Portadown, County Armagh, United Kingdom, BT63 5QQ |
United Kingdom, Devon | Barnstaple, Devon, United Kingdom, EX31 4JB |
United Kingdom, Essex | Westcliff on Sea, Essex, United Kingdom, SS0 0RY |
United Kingdom, Glamorgan | Port Talbot, Glamorgan, United Kingdom, SA12 7BR |
United Kingdom, Greater London | London, Greater London, United Kingdom, SE5 9RS |
United Kingdom, Staffordshire | Stoke-on-Trent, Staffordshire, United Kingdom, AT4 6QG |
United Kingdom, Sussex | Brighton, Sussex, United Kingdom, BN2 5BE |
United Kingdom, Warwickshire | Coventry, Warwickshire, United Kingdom, CV2 2DX |